Monthly Archives: July 2020

Profacgen Updated Its Anaerobic Fermentation Service

Recently, Profacgen updated its anaerobic fermentation service with the most advanced technologies, capabilities and experience.

Shirley, United States – July 30, 2020 /MarketersMedia/

Profacgen, a state-of-the-art protein service provider located in NY, provides custom protein services in the biological sciences. Recently, Profacgen updated its anaerobic fermentation service with the most advanced technologies, capabilities and experience.

Anaerobic fermentation is common to all bacteria and eukaryotes and is a metabolic process that converts carbohydrates (sugars) to organic acids, gases, or alcohols under anaerobic conditions. Thus, microorganisms are used to produce nutraceuticals or bacteriocins through the accumulation of various primary metabolites as well as complex secondary metabolites. Metabolic engineering strategies are often involved, so that the production of a certain metabolite can be highlighted or re-induced by overexpression and/or disruption of relevant metabolic genes.

Anaerobic fermentation has a wide range of applications. It can be used to produce a variety of industrial chemicals, such as ethanol, butanol, lactic acid, acetic acid, hydrogen and a variety of health food or antimicrobial molecules with medical or health benefits.

At Profacgen, efficient strains and process have been developed to produce many industrial materials using several bacterial strains: Saccharomyces, Lactobacillus, Escherichia coli, and Clostridium.

“As a leading manufacturer of industrial ingredients through anaerobic fermentation, we are sure to help with your fermentation product reach its full potential for the nutrition, cosmetic, personal care, industrial biotech and pharmaceutical industries in either small or large-scale development.” Commented Crystal, the chief marketing staff at Profacgen.

According to the information on the official website of Profacgen, examples of fermentation metabolites include:
Lactic acid
• Glycerol
• Methane
• Fatty acids
• Biogas production
• Modified/unmodified peptides, proteins

“With years of experience in providing contract research services, Profacgen has accumulated experience in virtually all aspects of protein development and production. We have, in the past 10 years, involved in hundreds of projects ranging from proof of concept studies to pilot manufacturing to mass production.” Add Crystal.

To know more about the Anaerobic Fermentation Service offered by Profacgen, please visit https://www.profacgen.com/anaerobic-fermentation.htm.

Contact Info:
Name: Ellen Burns
Email: Send Email
Organization: Profacgen
Website: https://www.profacgen.com

Source URL: https://marketersmedia.com/profacgen-updated-its-anaerobic-fermentation-service/88970662

Source: MarketersMedia

Release ID: 88970662

Matexcel Provides a Series of Testing Services That Comply with ASTM Standards

Matexcel, a leading service provider in material science, with the commitment to supplying better polymers, nanoparticles, and other materials for customers worldwide, provides a wide range of standard test services that comply with ASTM standards.

Bohemia – July 30, 2020 /MarketersMedia/

Matexcel, a leading service provider in material science, with the commitment to supplying better polymers, nanoparticles, and other materials for customers worldwide, provides a wide range of standard test services that comply with ASTM standards.

The ASTM safety standard is a compulsory certification standard in the United States. In the past few years, the global industry has undergone rapid development and tremendous changes. Countries and regions around the world, led by the European Union and the United States, have begun to revise relevant laws and standards.

The main task is to formulate characteristics and performance standards, test methods and procedures standards in the fields of materials, products, systems, and services, and promote the development and promotion of relevant knowledge. The purpose of ASTM is to promote public health and safety and improve the quality of life; to provide reliable raw materials, products, systems and services; to promote national, regional, and even international economies.

According to its official speaker, standard testing services at Matexcel include:

3D Imaging Standards

Adhesive Standards: Adhesive Material Classification System, Adhesives for Plastics, Construction Adhesives, Metal Bonding Adhesives, Tape and Labels, Wood Adhesives, Working Properties

Aerospace Material Standards: Contamination, Hydrogen Embrittlement, Qualification Testing of Aircraft Cleaning Materials, Space Simulation Test Methods, Thermal Protection, Transparent Enclosures and Materials

Analytical Chemistry Standards: Aluminum and Magnesium, Cu, Pb, Zn, Cd, Sn, Be, Precious Metals, their Alloys, and Related Metals, Iron, Steel, and Ferroalloys, Ni and Co and High Temperature Alloys, Ores, Concentrates, and Related Metallurgical Materials, Ti, Zr, W, Mo, Ta, Nb, Hf, Re

Atmospheric Analysis Standards: Ambient Atmospheres and Source Emissions, Assessment, Sampling, and Analysis of Microorganisms

“We are a customer-oriented company that aims to provide products and services to the global pharmaceutical and nanobiotechnology markets. Our experienced team of scientists has mastered a variety of techniques to solve interdisciplinary tasks. And we still have a lot of standard tests that have not been put online, but they can all be done. Please contact us for details.” Commented the official speaker from Matexcel.

To know more detailed information about the standard test service at Matexcel, please visit https://www.matexcel.com/services/standard-test/.

Contact Info:
Name: Johnson
Email: Send Email
Organization: Matexcel
Website: https://www.matexcel.com

Source URL: https://marketersmedia.com/matexcel-provides-a-series-of-testing-services-that-comply-with-astm-standards/88970660

Source: MarketersMedia

Release ID: 88970660

Bybit Announces an Estimated $110,000 COVID-19 Relief Donation to UNICEF from World Series of Trading Prize Fund

SINGAPORE / ACCESSWIRE / July 30, 2020 / Bybit has announced it will make a donation of up to 10 BTC to UNICEF, as part of its recently announced World Series of Trading (WSOT). The WSOT will gather traders from across the globe to compete for a prize pool worth 200 BTC, around $2.2 million at the current price. The WSOT event opened for pre-registration in early July, with over 8,000 participants having already signed up. The official registration to join the main event in August is now open.

Bybit has confirmed that 5% of the overall prize pool will be allocated to UNICEF to assist in their efforts helping vulnerable children recover from the fallout of the global pandemic. The donation comes thanks to a partnership with the New Zealand branch of UNICEF. According to the official announcement on their website, the Bybit donation is helping to plug a severe funding gap left by the pandemic crisis, which has put 1.6 billion children at risk.

"As the COVID-19 pandemic continues to cast its long shadow around the globe, its secondary impact is being felt by vulnerable children, who are the future of our world. Their situation is exacerbated by school closures, inadequate care, and shortages in food, sanitation supply, and medical resources. We at Bybit urgently feel it is incumbent upon us to support the ongoing efforts to safeguard our future," states Bybit CEO, Ben Zhou.

He continues:

"Together with our global community of traders, we would like to use this impetus to help lead positive action in the crypto space and give back to our very own home planet. With this in mind, we are pledging 5% of WSOT's final prize pool to UNICEF to assist in their work to save children's lives, defend their rights, and to help them fulfill their potential."

UNICEF NZ Executive Director Vivien Maidaborn added: "This is an exciting opportunity to partner with Bybit and better shape the lives of children significantly impacted by Covid-19. We thank Bybit and traders for their generous Bitcoin donations during this unprecedented global emergency."

About the World Series of Trading

The WSOT event is part of Bybit Games Calendar, which last year saw over 7,000 traders battle it out in a competition dubbed the "BTC Brawl." Bybit is aiming for the WSOT to attract even more traders who will compete alongside cryptocurrency influencers and legendary poker players, battling out for a prize pool of up to 200 BTC. Participants will be eligible for a 20% discount on trading fees, and the opportunity to earn up to $9,400 in USDT bonuses.

Bybit is now inviting traders to enroll for the main event. Registration is open until August 14, and warm-up participants must now re-register to secure their place. The WSOT contest will start on August 10 and run until the end of the month.

For more information on the event, please visit: https://www.bybit.com/en-US/wsot

About Bybit

Bybit is a global cryptocurrency derivatives exchange established in March 2018 and registered in the BVI. It is headquartered in Singapore. Bybit has a global user base comprising everyone from individual retail clients to professional derivatives traders.

For more information, please visit: https://www.bybit.com/

For updates, follow Bybit's social platforms on Twitter and Telegram.

Contact:

Dan Edelstein
pr@marketacross.com
+972-545-464-238

SOURCE: Bybit

ReleaseID: 599604

SharpSpring Sets Second Quarter 2020 Earnings Call for Thursday, August 13, 2020 at 4:30 p.m. ET

GAINESVILLE, FL / ACCESSWIRE / July 30, 2020 / SharpSpring, Inc. (NASDAQ:SHSP), a leading cloud-based marketing and sales automation platform, will hold a conference call on Thursday, August 13, 2020 at 4:30 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2020. Financial results will be issued in a press release prior to the call.

SharpSpring CEO Rick Carlson and Interim CFO Aaron Jackson will host the conference call, followed by a question and answer period.

Date: Thursday, August 13, 2020
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
U.S. dial-in number: 844-369-8770
International number: 862-298-0840

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Investor Relations at 949-574-3860.

The conference call will be broadcast live and available for replay here and via the investor relations section of the company's website at investors.sharpspring.com.

A replay of the conference call will be available after 7:30 p.m. Eastern time on the same day through August 27, 2020.

Toll-free replay number: 877-481-4010
International replay number: 919-882-2331
Replay ID: 35691

About SharpSpring, Inc.
SharpSpring, Inc. (NASDAQ:SHSP) is a rapidly growing, highly-rated global provider of affordable marketing automation delivered via a cloud-based Software-as-a Service (SaaS) platform. Thousands of businesses around the world rely on SharpSpring to generate leads, improve conversions to sales, and drive higher returns on marketing investments. Known for its innovation, open architecture and free customer support, SharpSpring offers flexible monthly contracts at a fraction of the price of competitors, making it an easy choice for growing businesses and digital marketing agencies. Learn more at sharpspring.com.

Company Contact:
Aaron Jackson
Interim Chief Financial Officer
Phone: 352-448-0967
Email: IR@sharpspring.com

Investor Relations:
Gateway Investor Relations
Matt Glover or Tom Colton
Phone: 949-574-3860
Email: SHSP@gatewayir.com

SOURCE: SharpSpring, Inc.

ReleaseID: 599451

Alibaba Printing: Solution for Millions of Red Packet Printing Singapore Demand

Alibaba Printing offers cheap yet finest red packet printing services all around the world today. From ready-made templates for customers to choose from up to customized red packets, Alibaba Printing can cater to every customer’s needs.

Singapore – July 30, 2020 /MarketersMedia/

Even international brands acknowledge the high-quality products wherein most of them would say that these red packets are very affordable for everyone to enjoy.

“We want every occasion to feel more special by offering a lot of creative designs for red packets while considering every person’s likes and dislikes because not all wants the same old designs. That’s why every day, we strive to create more aesthetic and modern designs that everyone will surely love.” — Anna, Lead Graphics Designer of Alibaba Printing. Considering that red packets are given not just once every year, Alibaba Printing aims to create red packets designs that are appropriate for each event to those who want to avail of their service.

“We grew up receiving a lot of red packets from our grandparents. Every single one of those red packets is very meaningful to us. That’s why I want to create various designs for everyone to choose from. Because every event should be special. We want to create different memories for various events. Thus, We aim for red packet templates that symbolize a lot of meanings for every single person,” — Chris Tan said, Marketing and Manager of Alibaba Printing.

With the demands continuously increasing every month, the company excels from different factors that will help its red packet printing Singapore services. Providing everyone with satisfactory outcomes that even some of them upload pictures on their social media accounts because they see it as something worth sharing.

With the current modernization of everything around us, the company ensures that its types of equipment will be always top-notch. Alibaba Printing never fails to provide up-to-date designs that any age will enjoy. But yet, of course, they will always stick to their mission that every product that they will create will never exceed a customer’s budget. That’s what Alibaba Printing’s clients love the most. “Aesthetically affordable” as some may say. And no one can argue with that.

Alibaba Printing will always ensure that every service that they will offer will always remain affordable to everyone but regardless of the price, the quality will always remain exceptional. Also, Alibaba Printing says that everyone should look out for newly released designs every week since they’ll make sure to provide every single customer with the design that they might prefer. But yet, of course, customers are free to send customized designs so that every red pocket can have that special meaning till the end.

Alibaba Printing is a flyer printing and flyer distribution company with different marketing services available for businesses to help them in their sales and promotion. The company expands its business portfolio to provide search engine optimization for small businesses who wish to have a foothold in the digital world.

To know more information, you may go here: https://www.alibabaprinting.sg/red-packet-printing-singapore/

Driving Directions: https://www.google.com/maps?cid=4815603585143824521

Contact Info:
Name: Chris Tan
Email: Send Email
Organization: Alibaba Printing
Address: Link@Amk, 3 Ang Mo Kio Street 62, 02-02, 569139
Phone: +65 9146 1431
Website: https://www.alibabaprinting.sg

Source URL: https://marketersmedia.com/alibaba-printing-solution-for-millions-of-red-packet-printing-singapore-demand/88962544

Source: MarketersMedia

Release ID: 88962544

Gordon Powers to Ramp Up 24-Hour Emergency Service Teams in Sydney

Leading electrical company to ramp up 24-hour emergency service teams in Sydney.

Sydney, Australia – July 30, 2020 /MarketersMedia/

Sydney, Australia, June 22, 2020 – Gordon Powers announced today that they are adding new teams of Level 2 electricians to be serving the Sydney area on a 24-hour basis. The company is hoping to help address the increasing demands of emergency electrical services to both residential and commercial properties.

The recent heavy rains have caused a significant number of instances of power interruptions in and around Sydney. The current lockdown period has also aggravated the seriousness of the situation as the movement of responding electrical emergency teams has been greatly limited in recent months. Numerous areas are currently left with no power, heavily affecting the lives and livelihood of hundreds of families as well as businesses operating in the area.

Charlie K, the owner and spokesperson of Gordon Powers has expressed the company’s commitment to helping with the emergency electrical services in the affected areas. “Thousands of lives have been greatly affected by the recent power outages across the Sydney region. We have added new personnel to our teams of Level 2 electricians who will be on 24-hour duties to serve the emergency needs of the public.”

“Our 24-hour services are considered to be among the most sought after programs of our company. Our customers love when our Level 2 electricians come within the hour after we receive the requests. For that reason, we strive to maintain excellence in the provision of our 24-hour emergency electrical services; as we do with all our other programs. We can be contacted at any time of the day through phone or through our website. Online booking also automatically saves our customers $50 off their fees.”, he added.

Gordon Powers is a team of highly-skilled electricians covering residential and commercial properties in Sydney. They service all across Sydney, providing level 2 and emergency electrical services.

Contact Info:
Name: Company Press
Email: Send Email
Organization: Gordon Powers
Phone: (02) 9199 7480
Website: https://gordonpowers.com.au/

Source URL: https://marketersmedia.com/gordon-powers-to-ramp-up-24-hour-emergency-service-teams-in-sydney/88970676

Source: MarketersMedia

Release ID: 88970676

Anaconda Mining Reports Second Quarter 2020 Results; Generates $5.8 Million of Cash Flow From Operating Activities in the First Half of 2020

TORONTO, ON / ACCESSWIRE / July 30, 2020 / Anaconda Mining Inc. ("Anaconda" or the "Company") (TSX:ANX)(OTCQX:ANXGF) is pleased to report its financial and operating results for the three and six months ended June 30, 2020 ("Q2 2020"). The condensed interim consolidated financial statements and management discussion & analysis documents can be found at www.sedar.com and the Company's website, www.anacondamining.com. All dollar amounts are in Canadian dollars unless otherwise noted.

Second Quarter 2020 Highlights

Anaconda sold 3,712 ounces of gold in Q2 2020, generating metal revenue of $8.4 million at an average realized gold price* of $2,249 (US$1,624) per ounce sold. As at June 30, 2020, the Company had 470 ounces of gold in gold doré inventory, which was subsequently sold in July.
Operating cash costs per ounce sold* at the Point Rousse Project in Q2 2020 were C$1,372 (US$991), compared to C$1,421 (US$1,062) in the three months ended June 30, 2019. Higher operating cash costs compared to Q1 2020 were the result of lower grade.
All-in sustaining cash costs per ounce sold* were C$1,828 (US$1,320) for Q2 2020, a 20% improvement over Q2 2019 when the Company sold fewer ounces and had increased development activity on the pushbacks to the Pine Cove pit.
The Company invested $1.4 million in its growth projects during Q2 2020, including $0.8 million on the Goldboro Gold Project and $0.6 million on exploration programs at the Tilt Cove Project and Point Rousse Project.
The Point Rousse Complex generated EBITDA* of $3.3 million in Q2 2020 and $7.8 million in the first half of 2020, compared with $0.7 million and $4.5 million for the respective 2019 periods.
Net income for the three months ended June 30, 2020 was $2.0 million, or $0.01 per share, compared to a net loss of $1.6 million, or $0.01 per share, for the three months ended June 30, 2019. The improved net income for the period was due to a $2.3 million increase in mine operating income and a $1.9 million gain recognized on the spin-out of Novamera Inc.
The Company initiated a 5,500-metre infill diamond drill program at the Goldboro Gold Project, to convert priority Inferred Mineral Resources, considered proximal to planned development under the ongoing feasibility study, into Indicated Mineral Resources.
On July 16, 2020, Anaconda announced a non-brokered private placement for up to $5.5 million, which will accelerate its highly prospective exploration and diamond drill programs in Atlantic Canada.
As at June 30, 2020, the Company had a cash balance of $5.5 million, working capital* of $5.8 million, and additional available liquidity of $0.3 million from an undrawn revolving line of credit facility.

*Refer to Non-IFRS Measures section below. A full reconciliation of Non-IFRS Measures can be found in the Management Discussion and Analysis for the three and six months ended June 30, 2020.

"During the second quarter, amid the ongoing uncertainty related to the COVID-19 pandemic, Anaconda sold 3,712 ounces of gold to generate metal revenue of $8.4 million. The Point Rousse operation has continued to operate uninterrupted in a safe and responsible manner and remains on track to produce and sell between 18,000 and 19,000 ounces of gold in 2020. Due to variability to the block model that has impacted tonnes and grade, we are revising our operating cash costs per ounce sold guidance to between C$1,150 and C$1,250 and expect the record high Canadian gold prices to more than offset the higher costs per ounce sold. We are continuing to advance the development of Argyle and expect to announce further details on the mineral resource and reserve soon, with the potential to accelerate the contribution of ore from Argyle to production. The second quarter also saw the announcement of strong drill results at Stog'er Tight and the initiation of a 5,500 metre drill program at the Goldboro Gold Project. Our $5.5 million of cash combined with our private placement of up to $5.51 million, which is expected to close on July 31, 2020, gives us the financial wherewithal to execute our growth strategy."

~Kevin Bullock, Chief Executive Officer, Anaconda Mining Inc.

Updated Guidance – Anaconda is maintaining its guidance to produce and sell between 18,000 and 19,000 ounces of gold in 2020. Mill feed in 2020 continues to be primarily from mining in the Pine Cove Pit, with mill feed expected to transition to mining from Argyle in the fourth quarter of 2020. As a result of lower grades experienced in the second quarter (see operational review below) and its resulting impact on operating cash costs per ounce, the Company is revising its operating cash costs per ounce guidance to between C$1,150 and C$1,250 per ounce of gold sold (US$850 – US$950 at an approximate exchange rate of 0.75), an increase from initial guidance of between C$1,050 and C$1,100 per ounce sold (US$775 – US$825 at an approximate exchange rate of 0.75). The impact of higher costs per ounce sold is expected to be more than offset by the significantly higher gold price per ounce, both in US and Canadian dollar terms.

Consolidated Results Summary

Financial Results

 

Three months ended

June 30, 2020

 
 

Three months ended

June 30, 2019

 
 

Six months ended

June 30, 2020

 
 

Six months ended

June 30, 2019

 

Revenue ($)

 
 
8,356,088
 
 
 
5,485,695
 
 
 
18,891,109
 
 
 
14,262,398
 

Cost of operations, including depletion and depreciation ($)

 
 
5,926,361
 
 
 
5,361,391
 
 
 
12,827,960
 
 
 
11,816,085
 

Mine operating income ($)

 
 
2,429,727
 
 
 
124,304
 
 
 
6,063,149
 
 
 
2,446,313
 

Net income (loss) ($)

 
 
1,981,864
 
 
 
(1,638,464
)
 
 
3,453,263
 
 
 
(480,613
)

Net income (loss) per share ($/share) – basic and diluted ($)

 
 
0.01
 
 
 
(0.01
)
 
 
0.03
 
 
 
(0.00
)

Cash generated from operating activities ($)

 
 
1,443,864
 
 
 
(2,770,728
)
 
 
5,823,989
 
 
 
1,364,346
 

Capital investment in property, mill and equipment ($)

 
 
530,983
 
 
 
1,235,873
 
 
 
1,190,325
 
 
 
1,525,050
 

Capital investment in exploration and evaluation assets ($)

 
 
1,391,057
 
 
 
2,538,791
 
 
 
2,487,687
 
 
 
6,896,181
 

Average realized gold price per ounce*

 
US$1,624
 
 
US$1,300
 
 
US$1,565
 
 
US$1,272
 

Operating cash costs per ounce sold*

 
US$991
 
 
US$1,062
 
 
US$918
 
 
US$858
 

All-in sustaining cash costs per ounce sold*
 
US$1,32
 
 
US$1,702
 
 
US$1,221
 
 
US$1,255
 

 
 
 
June 30, 2020
 
 
 
December 31, 2019
 

Total assets ($)

 
 
67,082,541
 
 
 
63,757,965
 

Non-current liabilities ($)

 
 
6,023,754
 
 
 
6,903,274
 

*Refer to Non-IFRS Measures section for reconciliation

Operational Results

 

Three months ended

June 30, 2020

 
 

Three months ended

June 30, 2019

 
 

Six months ended

June 30, 2020

 
 

Six months ended

June 30, 2019

 

Ore mined (t)

 
 
111,167
 
 
 
78,123
 
 
 
214,388
 
 
 
155,490
 

Waste mined (t)

 
 
561,950
 
 
 
427,425
 
 
 
1,123,714
 
 
 
706,837
 

Strip ratio

 
 
5.1
 
 
 
5.5
 
 
 
5.2
 
 
 
4.6
 

Ore milled (t)

 
 
118,333
 
 
 
96,895
 
 
 
231,469
 
 
 
176,653
 

Grade (g/t Au)

 
 
1.11
 
 
 
1.25
 
 
 
1.34
 
 
 
1.55
 

Recovery (%)

 
 
86.4
 
 
 
74.7
 
 
 
87.0
 
 
 
79.3
 

Gold ounces produced

 
 
3,657
 
 
 
2,907
 
 
 
8,654
 
 
 
7,083
 

Gold ounces sold

 
 
3,712
 
 
 
3,153
 
 
 
8,843
 
 
 
8,404
 

Second Quarter 2020 Review

Operational Overview – Anaconda produced 3,657 ounces of gold in the second quarter of 2020, a 26% increase over Q2 2019, due to better mill availability and resulting higher throughput. Low mill availability in Q2 2019 was due to planned maintenance on the main ball mill and unplanned maintenance for the regrind mill. However, gold production in Q2 was down 37% from the first quarter of 2020 due to lower grade, as the mine operation has observed some variability in grade and tonnage in certain lower levels of the Pine Cove pit. Year-to-date production of 8,654 ounces is consistent with the mine plan and the Company remains on track to meet guidance and produce and sell between 18,000 and 19,000 ounces of gold. In light of recent Argyle drill results and advancement of the related development plan, the Company is exploring opportunities to accelerate the development of Argyle in the second half of 2020.

During the second quarter of 2020, the mine operations produced 111,167 tonnes of ore from the Pine Cove Pit, a 42% increase from Q2 2019, which reflects the higher mining rate at the Pine Cove Pit compared to the lower tonnage profile of mining at Stog'er Tight, which was the main mining area in the prior period. The Company ended the second quarter with an ore stockpile of over 36,000 tonnes. The mine operations achieved a strip ratio of 5.1 waste tonnes to ore tonnes at the Pine Cove Pit, a decrease compared to Q1 2020 as the operation moves into the bottom levels of the Pine Cove Pit.

The Pine Cove Mill processed 118,333 tonnes during Q2 2020, an increase of 22% compared to the second quarter of 2019. Since the challenges experienced in the second quarter of 2019, the mill has operated consistently and effectively, maintaining high levels of mill availability and throughput since. Average grade during Q2 2020 was 1.11 g/t, an 11% decrease over the second quarter of 2019, when mill feed was primarily from the higher-grade Stog'er Tight Mine, and a decrease of 31% from Q1 2020 as the mine experienced variability to the block model in certain lower areas of the pit. The mill achieved an average recovery rate of 86.4%, an increase from 74.7% achieved in Q2 2019 despite the lower grade profile in Q2 2020. The higher throughput and better recovery resulted in gold production of 3,657 ounces, an increase of 26% compared to the second quarter of 2019.

Financial Results – Anaconda sold 3,712 ounces of gold during the second quarter of 2020, generating gold revenue of $8.3 million at an average realized gold price of C$2,249 per ounce (US$1,624).

Operating expenses for the three months ended June 30, 2020 were $5,101,316, compared to $4,337,552 in the three months ended June 30, 2019. Operating expenses for Q2 2020 included mining costs of $2,589,012 and were higher than the comparative period primarily due to the 33% increase in material mined at Pine Cove compared to Stog'er Tight in Q2 2019. Processing costs of $2,466,037 in Q2 2020 were also higher than the comparative period due to the 22% increase in ore tonnes milled during the period. Operating cash costs per ounce sold in the first half of 2020 were C$1,252 (US$918), higher than the upper range of the initial guidance provided for operating cash costs per ounce sold, due to lower than planned grades in the second quarter of 2020. The Company has now revised its operating cash costs per ounce guidance to between C$1,150 and C$1,250 per ounce of gold sold (US$850 – US$950 at an approximate exchange rate of 0.75).

There was no royalty expense for Q2 2020 compared to $145,436 in Q2 2019, as production in the prior year was predominantly from Stog'er Tight, which carries a 3% net smelter royalty. Depletion and depreciation for the three months ended June 30, 2020 was $825,045, consistent with $878,403 recognized in Q2 2019.

Mine operating income for Q2 2020 was $2,429,727, compared to $124,304 in the corresponding period of 2019, with higher comparable operating costs during Q2 2020 being more than offset by higher revenue resulting from significantly higher gold prices.

Corporate administration costs were $771,640 for Q2 2020, a decrease of 28% from Q2 2019, as the Company has streamlined corporate costs over the second half of 2019. The Company also recorded a one-time gain of $1,902,894 associated with the spin-out of Novamera and its narrow vein mining technology.

Finance expense for the quarter was $52,521 for Q2 2020, compared to $156,346 for the three months ended June 30, 2019. Finance costs in the prior year were higher as a result of a gold loan that was delivered into in Q2 2019.

In Q2 2020, the Company recorded a write-down of exploration and evaluation assets of $15,310 due to the termination of an option agreement.

Net comprehensive income for the three months ended June 30, 2020, was $1,981,864, or $0.01 per share, compared to a net loss of $1,638,464, or $0.01 per share. The improvement compared to the three months ended June 30, 2019 was the result of higher mine operating income and the gain of $1,902,894 related to the spin-out of Novamera. These factors were offset by a higher net income tax expense, as the Company recorded a current income tax expense of $235,000 relating to provincial mining tax and a deferred income tax expense of $1,275,000 during the three months ended June 30, 2020 (three months ended June 30, 2019 – recovery of $20,000 and an expense of $54,000, respectively).

Financial Position and Cash Flow Analysis

As at June 30, 2020, the Company had working capital of $5,778,954, which included cash and cash equivalents of $5,534,687. Trade and other payables have decreased since the prior year mainly due to severance payments and timing of payables. Current taxes payable reflect the Newfoundland mining taxes payable for 2019 and an estimate for the taxes for the first half of 2020. Working capital as at period end was impacted by net assets held for sale of $1,437,120 related to the sale of ExploreCo. Subsequent to June 30, 2020, mining taxes of $563,126 relating to 2019 were paid. The current portion of loans includes $1,444,874 outstanding from a $5.0 million term loan with the Royal Bank of Canada ("RBC"), entered into in March 2019. The term loan carries a fixed interest rate of 4.6% and performance guarantee fee by Export Development Canada ("EDC") of 1.85%, payable quarterly based on the proportional amount outstanding.

Anaconda generated $1,443,864 in operating cash flows during the three months ended June 30, 2020, after accounting for corporate administration costs of $771,640. The Point Rousse Project generated EBITDA of $3,176,968, based on gold sales of 3,712 ounces at an average gold price of C$2,249 per ounce sold and operating cash costs of C$1,372 per ounce sold. The Company's operating cash flows were impacted by the $850,243 reduction in accounts payable and accrued liabilities during Q2 2020.

During Q2 2020, the Company continued to invest in its key growth projects in Newfoundland and Nova Scotia. The Company spent $1,391,057 on exploration and evaluation assets (adjusted for amounts included in trade payables and accruals at June 30, 2020), primarily on the continued advancement of the Goldboro Gold Project and exploration activities at Tilt Cove, and invested $530,983 into capitalized stripping at the Pine Cove Pit and sustaining capital for the Pine Cove Mill. During the three months ended June 30, 2020, the Company also generated $113,570 in net proceeds from the sale of marketable securities.

Financing activities during the three months ended June 30, 2020 were limited to the repayment of loans and lease obligations, including the RBC term loan. The Company also received $87,500 from the exercise of stock options.

Non-IFRS Measures

Anaconda has included in this press release certain non-IFRS performance measures as detailed below. In the gold mining industry, these are common performance measures but may not be comparable to similar measures presented by other issuers. The Company believes that, in addition to conventional measures prepared in accordance with IFRS, certain investors use this information to evaluate the Company's performance and ability to generate cash flow. Accordingly, it is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.

Operating Cash Costs per Ounce of Gold – Anaconda calculates operating cash costs per ounce by dividing operating expenses per the consolidated statement of operations, net of silver sales by-product revenue, by the gold ounces sold during the applicable period. Operating expenses include mine site operating costs such as mining, processing and administration as well as royalties, however excludes depletion and depreciation and rehabilitation costs.

All-In Sustaining Costs per Ounce of Gold – Anaconda has adopted an all-in sustaining cost performance measure that reflects all of the expenditures that are required to produce an ounce of gold from current operations. While there is no standardized meaning of the measure across the industry, the Company's definition conforms to the all-in sustaining cost definition as set out by the World Gold Council in its guidance dated June 27, 2013. The World Gold Council is a non-regulatory, non-profit organization established in 1987 whose members include global senior mining companies. The Company believes that this measure will be useful to external users in assessing operating performance and the ability to generate free cash flow from current operations.

The Company defines all-in sustaining costs as the sum of operating cash costs (per above), sustaining capital (capital required to maintain current operations at existing levels), corporate administration costs, sustaining exploration, and rehabilitation accretion and amortization related to current operations. All-in sustaining costs excludes capital expenditures for significant improvements at existing operations deemed to be expansionary in nature, exploration and evaluation related to growth projects, financing costs, debt repayments, and taxes. Canadian and US dollars are noted for realized gold price, operating cash costs per ounce of gold and all-in sustaining costs per ounce of gold. Both currencies are considered relevant and the Company uses the average foreign exchange rate for the period.

Average Realized Gold Price per Ounce Sold – In the gold mining industry, average realized gold price per ounce sold is a common performance measure that does not have any standardized meaning. The most directly comparable measure prepared in accordance with IFRS is gold revenue. The measure is intended to assist readers in evaluating the revenue received in a period from each ounce of gold sold.

Earnings before Interest, Taxes, Depreciation and Amortization ("EBITDA") – EBITDA is earnings before finance expense, deferred income tax expense and depletion and depreciation.

Point Rousse Project EBITDA is EBITDA before corporate administration and other expenses (income).

Working Capital – Working capital is a common measure of near-term liquidity and is calculated by deducting current liabilities from current assets.

ABOUT ANACONDA

Anaconda is a TSX and OTCQX-listed gold mining, development, and exploration company, focused in Atlantic Canada. The company operates mining and milling operations in the prolific Baie Verte Mining District of Newfoundland which includes the fully-permitted Pine Cove Mill, tailings facility and deep-water port, as well as ~11,000 hectares of highly prospective mineral lands including those adjacent to the past producing, high-grade Nugget Pond Mine at its Tilt Cove Gold Project. Anaconda is also developing the Goldboro Gold Project in Nova Scotia, a high-grade resource and the subject of an on-going feasibility study.

FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking information" within the meaning of applicable Canadian and United States securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "does not anticipate", or "believes" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", or "will be taken", "occur", or "be achieved". Forward-looking information is based on the opinions and estimates of management at the date the information is made, and is based on a number of assumptions and is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Anaconda to be materially different from those expressed or implied by such forward-looking information, including risks associated with the exploration, development and mining such as economic factors as they effect exploration, future commodity prices, changes in foreign exchange and interest rates, actual results of current production, development and exploration activities, government regulation, political or economic developments, risks related to the COVID-19 pandemic, environmental risks, permitting timelines, capital expenditures, operating or technical difficulties in connection with development activities, employee relations, the speculative nature of gold exploration and development, including the risks of diminishing quantities of grades of resources, contests over title to properties, and changes in project parameters as plans continue to be refined as well as those risk factors discussed in Anaconda's annual information form for the year ended December 31, 2019, available on www.sedar.com. Although Anaconda has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. Anaconda does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

FOR ADDITIONAL INFORMATION CONTACT:

Anaconda Mining Inc.
Kevin Bullock
President and CEO
(647) 388-1842
kbullock@anacondamining.com

Reseau ProMarket Inc.
Dany Cenac Robert
Investor Relations
(514) 722-2276 x456
Dany.Cenac-Robert@ReseauProMarket.com

Anaconda Mining Inc.
Lynn Hammond
VP, Corporate Affairs
(709) 330-1260
lhammond@anacondamining.com

SOURCE: Anaconda Mining Inc.

ReleaseID: 599546

Renaissance Gold Generates New Royalty on Its South Roberts Project in Nevada

VANCOUVER, BC / ACCESSWIRE / July 30, 2020 / Renaissance Gold Inc. (TSXV:REN)(OTCQB:RNSGF) ("RenGold" or the "Company") is pleased to announce that it has entered into a Purchase Agreement ("Agreement") with a private US Company on its South Roberts Project in Eureka County, Nevada. RenGold will transfer 100% interest in the South Roberts property in exchange for a 1% net smelter return royalty (NSR) interest on any future production from the "SR" claims and a 0.5% NSR interest on any future production from the "RW" claims (Figure 1).

South Roberts Property

The South Roberts Project, Eureka County, Nevada lies on the Battle Mountain-Eureka trend of world class gold deposits, approximately 10 km. to the southeast of McEwen Mining's Gold Bar Mine (Figure 1). The project targets concealed Carlin-type gold mineralization occurring along major crustal structures and hosted in favorable lower-plate carbonate stratigraphy. The project has been explored in two prior earn-in agreements with McEwen Mining (NYSE;TSX.V:MUX) and S2 Resources Ltd. (ASX:S2R). Both former partners explored the property with geophysics and drilling, and collectively completed 4 reverse circulation and 5 core holes. Drilling encountered collapse breccia textures, decalcification and minor silicification with anomalous arsenic, antimony, mercury and gold in upper plate siliciclastic rocks and at the unconformity between the Mississippian Webb Fm. and the Devonian Devils Gate Limestone, a favorable host horizon at the Rain deposit on the Carlin Trend and the nearby Afgan deposit. These results may represent a distal signature of Carlin-type mineralization on this contact. The most favorable Devonian host stratigraphy has not been adequately drill tested, and provides an opportunity for a world class discovery.

Qualified Person

All technical data disclosed in this press release has been verified by RenGold's Qualified Person, Robert Felder, M.Sc. and Certified Professional Geologist (#11012) as recognized by the American Institute of Professional Geologists (AIPG).

About Renaissance Gold Inc.

Renaissance Gold Inc. is a western US focused prospect generator utilizing a joint venture business model. On June 10, 2020, the Company announced a merger-of-equals combination with Evrim Resources Inc. to form a new exploration and royalty business named Orogen Royalties Inc. ("Orogen"). Orogen will focus on project generation as has been the history of both Renaissance and Evrim but with a renewed focus on organic royalty creation and royalty acquisition. Underpinning Orogen's royalty portfolio is the Ermitaño West gold deposit in Sonora, Mexico (2% NSR) being developed by First Majestic Silver Corp. and planned to be in production in 2021, and the Silicon gold project (1% NSR) in Nevada, USA, being advanced by AngloGold Ashanti NA. The transaction is expected to close around August 18, 2020, subject to shareholder and regulatory approval. Shareholders are reminded to vote their securities in advance of the Company's upcoming special meeting on August 12, 2020.

By: Robert Felder, President & CEO

For further information, contact:

Robert Felder 775-337-1545 or bfelder@rengold.com
Ronald Parratt 775-337-1545 or rparratt@rengold.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although Renaissance Gold Inc. believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of Renaissance Gold Inc's management on the date the statements are made. Except as required by law, Renaissance Gold Inc. undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

SOURCE: Renaissance Gold Inc.

ReleaseID: 599560

Theralase Reports on Phase II Non-Muscle Invasive Bladder Cancer (“NMIBC”) Clinical Study (“Study II”) Progress

Results of the First 12 patients enrolled in the Phase II NMIBC Clinical Study Demonstrate a 58.3% Response 90 Days Post Initial Treatment

TORONTO, ON / ACCESSWIRE / July 30, 2020 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds ("PDC") and their associated drug formulations to safely and effectively destroy various cancers is pleased to provide an update on its Phase II Non-Muscle Invasive Bladder Cancer ("NMIBC") Clinical Study ("Study II").

The primary purpose of Study II is to discover if the TLD-1433 ("Study Drug") combined with TLC-3200 ("Study Device") (collectively the "Study Treatment") are effective in the destruction of Bacillus Calmette-Guérin ("BCG")-Unresponsive Non-Muscle Invasive Bladder Cancer ("NMIBC").

All Canadian clinical study sites currently remain closed for new patient enrollment and treatment; however, Canadian clinical study sites, who have already enrolled and treated patients, are providing second treatments. The Company is preparing to launch a fifth Canadian clinical study site later in the year.

The Company is preparing to launch a number of US based clinical sites later in the year, subject to the United States economy recovering from COVID-19; however, it is anticipated due to the severity of the COVID-19 pandemic in the United States, that these sites will not be open to commence enrollment and treatment of patients until 2021.

Study II enrolled and treated 12 patients, with the following results:

Patient Status

Number of Patients

Percentage

First Treatment Provided

12

100.0%

Patients Eligible to Receive Second Treatment

8

66.7%

Second Treatment to be Provided

5

41.7%

Second Treatment Provided

3

25.0%

 
 
 

Response at 90 Days Post Initial Treatment

7

58.3%

Complete Response at 90 Days Post Initial Treatment

3

25.0%

 
 
 

Patients Removed from Study II

4

33.3%

 
 
 

Study II Interim Data Analysis:

Of the 7 patients, who demonstrated a Response to the Study Treatment defined as negative cystoscopy (no evidence of cancer in their bladders) or negative urine cytology (no evidence of the urothelial carcinoma cells in their urine)) at 90 days post initial treatment:

43% achieved a Complete Response ("CR") (negative cystoscopy and negative urine cytology).
43% achieved a Response (negative cystoscopy and positive or suspicious cytology)
14% achieved a Response (suspicious cystoscopy and negative cytology)

The patients who responded to the Study Treatment are currently under medical review to assess the cause of the suspicious cystoscopy by directed bladder biopsy and the cause of the positive or suspicious cytology by repeating the urine cytology analysis. If found to be negative, these patients will be allocated to the CR column. If positive or suspicious again, then Computerized Tomography ("CT") Scan imaging and/or prostatic biopsies will be conducted to rule out Upper Tract Urothelial Cell Carcinoma ("UTUCC"). If UTUCC is proven to exist, then according to FDA's Bacillus Calmete Guérin ("BCG")-Unresponsive Guidelines to Industry, issued in February 2018, these patients will be classified as CR, as only the bladder was treated by the Study Treatment and not non-addressable areas of the urinary system.

Of the 4 patients that were removed from Study II, the clinical protocol in effect at the time stated in the patient withdrawal criteria that "Patients found to have at Day 90 new T1 high-grade disease, with or without CIS" and "Patients found to have unchanged or worsening CIS at 3 months" will be removed from Study II.

Of the 4 patients removed from the Study, they presented with "unchanged CIS at 3 months".

This was an oversight on behalf of the Company and the clinical protocol has since been updated to remove these two specific patient withdrawal criteria, maintaining the key patient withdrawal criteria of NMIBC progression, which includes "Progression to Muscle Invasive Bladder Cancer ("MIBC")" and "Progression to metastatic disease". These changes, had they been in place, would have led to the retreatment of these 4 patients and an opportunity to achieve CR for these patients at a later medical assessment point.

Study Treatment Optimizations:

Additional optimizations to the clinical study protocol that have been implemented for all future patients to be enrolled and treated in Study II and for the five patients yet to receive their second treatment, include:

Bladder Volume Calculation:

The clinical protocol did not clearly define the bladder volume calculation to be used by the pharmacy and the principal investigator to determine bladder size for administration of the Study Drug and Study Device, respectively. Average bladder volume voided over a 3 day period was used as opposed to a percentage of the maximum bladder volume voided.

Study Device Treatment Time:

The Study Device treatment time was based on detected bladder irradiance, which varied dramatically inside patient bladders due to shape, volume and bladder wall reflection. This led to undertreatment of certain patients with the Study Device by up to 87.9%. This has been modified to now determine Study Device treatment time based solely on the new bladder volume calculation, resulting in a more consistent Study Device treatment time across patients.

Summary:

The total of these Study II variances (Study Drug Volume, Study Device Volume and Study Device Treatment Time) have led to all 12 patients being undertreated by the Study Treatment from between 30.9% and 154.3%.

About Study II

Study II utilizes the Therapeutic Dose (0.70 mg/cm2) of TLD-1433 and is focused on the enrollment and treatment of approximately 100 BCG-Unresponsive NMIBC patients presenting with Carcinoma In-Situ ("CIS") in approximately 20 clinical study sites located in Canada and the US.

Study II has a:

Primary endpoint of efficacy (defined by CR) at any point in time
Secondary endpoint of duration of CR at 360 days post-initial CR
Tertiary endpoint of safety measured by incidence and severity of Adverse Events ("AEs") grade 4 or higher that do not resolve within 360 days post-initial CR

"For single-arm trials of patients with BCG-unresponsive disease, the FDA defines a CR as at least one of the following:

Negative cystoscopy and negative (including atypical) urine cytology
Positive cystoscopy with biopsy-proven benign or low-grade NMIBC and negative cytology
For intravesical therapies without systemic toxicity, negative cystoscopy with malignant urine cytology, if cancer is found in the upper tract or prostatic urethra and random bladder biopsies are negative.

Intravesical instillation does not deliver the investigational drug to the upper tract or prostatic urethra; therefore, the development of disease in these areas cannot be attributed to a lack of activity of the investigational drug. Thus, sponsors can consider patients with new malignant lesions of the upper tract or prostatic urethra, who have received intravesical therapy to have achieved a CR in the primary analysis; however, sponsors should record these lesions and conduct sensitivity analyses in which these patients are not considered to have achieved a CR." 1

Forward Looking Statement

This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Such statements include, but are not limited to, statements regarding the Company's proposed development plans with respect to Photo Dynamic Compounds and their drug formulations. Wherever possible, words such as "may", "would", "could", "should", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions including with respect to the ability of the Company to: adequately fund, secure the requisite regulatory approvals to commence and successfully complete a Phase II NMIBC clinical study in a timely fashion and implement its development plans. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements; including, without limitation, those listed in the filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the press release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. The Company disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

For More Information:

1.866.THE.LASE (843-5273)
416.699.LASE (5273)
www.theralase.com

Kristina Hachey
Chief Financial Officer
khachey@theralase.com

1 "BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drugs and Biologics for Treatment – Guidance for Industry" Dated: February 2018

SOURCE: Theralase® Technologies Inc.

ReleaseID: 599591

Talisker Begins Trading on the OTCQX Market

TORONTO, ON / ACCESSWIRE / July 30, 2020 / Talisker Resources Ltd. ("Talisker" or the "Company") (CSE:TSK)(OTCQX:TSKFF) is pleased to announce that the Company has qualified to trade on the OTCQX® Best Market. Talisker shares will begin trading today on the OTCQX under the symbol "TSKFF".

The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors.

Terry Harbort, President & CEO of Talisker stated, "We are pleased to have qualified to trade on the OTCQX Market which we anticipate will provide Talisker with wider visibility to the investment community to broaden our shareholder base and strengthen shareholder value."

About Talisker Resources Ltd.

Talisker (taliskerresources.com) is a junior resource company involved in the exploration of gold projects in British Columbia, Canada. Talisker's projects include the Bralorne Gold Complex, an advanced stage project with significant exploration potential from a historical high-grade producing gold mine as well as its Spences Bridge Project where the Company holds ~85% of the emerging Spences Bridge Gold Belt and several other early stage Greenfields projects. With its properties comprising 291,339 hectares over 322 claims, six leases and 181 crown grant claims, Talisker is a dominant exploration player in the south-central British Columbia. The Company is well funded to advance its aggressive systematic exploration program at its projects.

For further information please contact:

Terry Harbort, Chief Executive Officer or
terry.harbort@taliskerresources.com
+1 416 361 2808

Carrie Howes, Director, Investor Relations
carrie.howes@taliskerresources.com
+1 416 837 0075

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

SOURCE: Talisker Resources Ltd.

ReleaseID: 599571